TGF-β1 significantly downregulates NO synthesis in colon carcinoma cells via an intracellular mechanism [142], suggesting that targeting TGF-β1 could serve as a cancer therapy by upregulating NO production. Here, TGFB1 is linked to colon carcinoma.